secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K
Filed at:   2024-09-26T23:59:59+00:00
Accession:  0001453687-24-000110
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Cartesian Therapeutics completes automatic conversion of Series B Preferred Stock; 23.9M common shares outstanding
--------------------------------------------------------------------------------

- Stockholders at Sept 20 special meeting approved issuance of common shares from Series B Preferred Stock conversion.
- Automatic conversion of all Series B Non-Voting Convertible Preferred Stock completed on Sept 25, 2024.
- Following conversion, there are 23,893,525 shares of common stock issued and outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000145368724000110/0001453687-24-000110-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000145368724000110/rnac-20240925.htm
  HTML page:      https://secwatch.observer/filing/0001453687-24-000110

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer